hm1.jpg

Cancer specialist Artios Pharma has raised $153m in a Series C Financing led by Omega Funds and TCG X to progress its clinical pipeline.

Reinräume zur Pharmaproduktion gehören zum Angebot des Fonds. © Siemens

AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector.

Dr Neil Butt is the new Chief Executive Officer at Oxford-based Orbit Discovery.

Synaffix NV

Synaffix has nonexclusivey licensed its award-winning ADC technologies to Chinese ProfoundBio in an up to $246m deal

Fabrizio Landi, Founder and Managing Partner © Panakès Partners

Italian venture capital firm Panakès Partners, previously active in medtech, has closed the €150m purple fund with the goal to invest in underserved European Life Science companies.

© BioNTech

Mainz-based BioNTech is expanding its portfolio for cancer therapies with the neoantigen TCR Cell Therapy R&D pipeline and manufacturing site from Gilead Science subsidiary Kite Pharmaceuticals.

© Nanosyrinx plc

Coventry-based NanoSyrinx plc has raised £6.2m in seed financing to develop a new cell engineering tool for novel targeted therapeutic modalities.

stevepb / Pixabay

Dutch immunotherapy company ISA Pharmaceuticals has closed a €26m funding round that will go towards advancing its therapy targeting HPV16-related cancers.

While Unilever moved its headquarters from London to Rotterdam due to Brexit, laundry products will still be made in the UK. © GrindtXX, Wikimedia.

As part of its ‘Clean Future’ strategy, Unilever NV has licensed enzyme technology from Arzeda Inc. to help rid detergent production of fossil carbon.

Malene Brondberg, Chief Financial Officer of Nordic Nanovector since May 2020, became Interim Chief Executive Officer of the company.